Researchers from the universities in Konstanz and Vienna discover a new class of antibiotic that selectively targets Neisseria gonorrhoeae, the bacterium that causes gonorrhea. These substances ...

The abrupt halt has stranded about 1,000 samples of gonorrhea and other sexually transmitted pathogens that had not yet been processed, and perhaps dozens more headed to the agency. There are as ...

the bacterium that causes gonorrhea. These substances trigger a self-destruction program, which also operates in multi-resistant variants of the pathogen. The findings are published in the current ...

A critical laboratory for surveilling sexually transmitted diseases (STDs) in the U.S. has been lost in the Trump ...

Those are infections in which the pathogen that causes gonorrhea passes beyond normally infected sites — the genital, rectal or mouth areas — into the bloodstream and other parts of the body.

A new class of antibiotic has been found to be safe and effective in treating gonorrhea in late-stage trials, according to a new study published Monday in The Lancet. The drug, called gepotidacin ...

Gonorrhea is on the verge of incurability, with just one antibiotic that still reliably works against the sexually transmitted infection. But on Monday, The Lancet medical journal reported ...

A newly approved antibiotic to treat urinary tract infections may also help fight drug-resistant gonorrhea, a new study shows. The medication, called gepotidacin, could become the first new ...

Ultimately, new treatment strategies and novel antimicrobials are essential for the effective treatment of gonorrhea. † Genetic resistance determinants (penA, mtrR and penB) elucidated.